Abstract
Twenty-seven Escherichia coli test strains that were not susceptible to cephalothin were tested for susceptibility to cefazolin, cefamandole, and ceforanide. By zone-size criteria (≥ 18 mm), 67% of E. coli were susceptible to cefazolin and cefamandole, and 93% were susceptible to ceforanide. By microtiter assay (MIC ≤ 8 μg/ml), 88% were susceptible to cefazolin and cefamandole, and 94% were susceptible to ceforanide. The results support susceptibility testing of E. coli with specific first- or second-generation cephalosporins rather than with class agents.
| Original language | English |
|---|---|
| Pages (from-to) | 151-153 |
| Number of pages | 3 |
| Journal | Clinical Therapeutics |
| Volume | 7 |
| Issue number | 2 |
| State | Published - 1985 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver